Zydus Wellness Q2 FY27 Results (NSE: ZYDUSWELL)

· Analysis by Alpha Inflection

Signal: Loss reversed

The read

The key inflection is a return to positive consolidated PAT of 51 million from a 528 million loss, supported by gross-margin expansion to 61.2% from 52.9% and the absence of last year's 342 million exceptional charge; however, EBITDA margin at 7.6% remains below the 17.1% Q1FY27 level and group PAT is still below the 1,189 million June quarter, so the recovery is not yet a clean acceleration.

Zydus Wellness Q2 FY27 key financials
MetricValueYoYQoQ
Revenue₹1,126.6 Cr+73.2%-21.6%
EBIT₹28.4 CrTurned positive from loss
Net profit₹5.1 CrTurned positive from (528)
EPS₹0.16Turned positive from loss
EBIT margin7.6%

P&L walk

Consolidated revenue rose 73.2% YoY to 11,266 million, gross margin expanded 830bps to 61.2%, and EBITDA margin improved to 7.6% from 3.5%; PAT recovered to 51 million from a 528 million loss, helped by the absence of the 342 million exceptional charge and lower tax, but sequential momentum moderated sharply from the seasonally strong June quarter.

Segments

The group-level result is materially larger than standalone: consolidated Q2 revenue was 11,266 million versus standalone revenue of 1,668 million, and consolidated PAT was 51 million versus standalone PAT of 116 million, indicating that subsidiaries dragged group profitability despite driving most revenue.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.